PFA
AZN icon

Professional Financial Advisors’s AstraZeneca AZN Stock Holding History

Professional Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28
Closed -$3K – 403
2021
Q1 		$3K Hold
28
– – ﹤0.01% 308
2020
Q4 		$3K Buy
+28
New +$2.97K ﹤0.01% 311

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Professional Financial Advisors's AZN Position: Q2 2021 in Review

Professional Financial Advisors sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 28 shares — an estimated $3K sold.

Professional Financial Advisors first reported a position in AZN in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

  • Professional Financial Advisors reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
  • Professional Financial Advisors sold 28 AstraZeneca shares in Q2 2021, an estimated $3K.
  • Professional Financial Advisors first reported a position in AstraZeneca in Q4 2020 and held it in 2 quarters.
  • Professional Financial Advisors's AstraZeneca position peaked at $3K in Q1 2021.
  • 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Professional Financial Advisors's 13F filing for Q2 2021, filed 20 Jul 2021.